Whether you engage us at literature review, pilot campaign, or steady-state commercial supply, you get the same team, the same batch-record chain, and the same director sign-off on every MSA.
Timelines vary by molecule and scope; the shape below applies to every engagement.
Two-line brief → mutual NDA signed within one business day.
Chemistry, regulatory, and cost feasibility scored before quotation.
Milestone-based development quote plus per-kg commercial pricing model.
Milestone-tracked development with monthly technical calls.
Validated commercial supply with signed batch records on every campaign.
Human QA sign-off on every batch, no delegation
5-Why + fishbone RCA, CAPA effectiveness verification
Quarterly window reserved for client-led audits
Live registrations across APAC, LATAM, EMEA
Recent engagement
Full transition from EU-based supplier — dossier bridging, tech transfer, and validated commercial supply completed with zero regulatory findings.
A ten-page PDF written by our subject-matter lead for this capability. Delivered by email within one business day, always signed by a director.
cGMP API and intermediates production at pilot and commercial scale.
Method development to ICH Q2(R2) validation, plus QC release testing and stability studies.
8-14 week engagements that produce 2-3 viable synthetic routes with scorecards.
Site-to-site and stage-to-stage transfers with signed transfer protocols.
Small-molecule discovery, process R&D, and green-chemistry alternatives on every route.
Book a call with the CDMO & CMO lead — no gatekeeping, no BD filter.
Chat with us